Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,147,652
  • Shares Outstanding, K 128,218
  • Annual Sales, $ 338,300 K
  • Annual Income, $ 17,950 K
  • 60-Month Beta 1.88
  • Price/Sales 6.08
  • Price/Cash Flow 67.98
  • Price/Book 12.87
Trade ORGO with:

Options Overview

Details
  • Implied Volatility 98.30%
  • Historical Volatility 60.04%
  • IV Percentile 45%
  • IV Rank 30.28%
  • IV High 138.13% on 01/14/21
  • IV Low 80.99% on 04/30/21
  • Put/Call Vol Ratio 157.25
  • Today's Volume 633
  • Volume Avg (30-Day) 377
  • Put/Call OI Ratio 1.17
  • Today's Open Interest 4,336
  • Open Int (30-Day) 3,517

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.06
  • Number of Estimates 2
  • High Estimate 0.07
  • Low Estimate 0.06
  • Prior Year -0.05
  • Growth Rate Est. (year over year) +220.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.70 +12.31%
on 06/11/21
19.75 -16.40%
on 05/27/21
-0.15 (-0.90%)
since 05/18/21
3-Month
14.70 +12.31%
on 06/11/21
24.34 -32.16%
on 04/09/21
-0.57 (-3.34%)
since 03/18/21
52-Week
3.23 +411.15%
on 07/14/20
24.34 -32.16%
on 04/09/21
+12.69 (+332.20%)
since 06/18/20

Most Recent Stories

More News
Amryt (AMYT) NDA for Skin Disorder Drug Gets Priority Review

Amryt (AMYT) is seeking approval for Oleogel-S10 as a potential treatment for patients with rare and distressing genetic skin disorder, epidermolysis bullosa.

ADPT : 39.45 (-0.93%)
XNCR : 36.94 (-0.27%)
ORGO : 16.51 (-1.43%)
AMYT : 11.75 (+0.09%)
Verrica's (VRCA) Skin Disease Candidate Approval Gets Delayed

Verrica's (VRCA) NDA for lead candidate, VP-102, a drug-device combination treatment for skin disease, molluscum, is under review. FDA delays decision on potential approval for the candidate by three months....

ZTS : 185.39 (-0.56%)
XNCR : 36.94 (-0.27%)
VRCA : 11.57 (-6.92%)
ORGO : 16.51 (-1.43%)
3 Biotech Stocks Wall Street Predicts Will Rally By 45% or More

The biotech industry saw solid growth last year driven by the demand for therapies to combat COVID-19. But advances in technology helped biotech companies deliver impressive drug candidates for treating...

ORGO : 16.51 (-1.43%)
BDSI : 3.64 (+1.11%)
CSBR : 8.45 (-2.31%)
Organogenesis (ORGO) Stock Jumps 7.7%: Will It Continue to Soar?

Organogenesis (ORGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase...

ORGO : 16.51 (-1.43%)
Thinking about trading options or stock in Ford, Organogenesis, Beyond Meat, Dollar Tree, or Plug Power?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for F, ORGO, BYND, DLTR, and PLUG.

BYND : 145.37 (-2.83%)
DLTR : 100.32 (-0.37%)
ORGO : 16.51 (-1.43%)
PLUG : 29.17 (-2.28%)
F : 14.52 (-1.69%)
Crocs Set to Join S&P MidCap 400 and Organogenesis to Join S&P SmallCap 600

, /PRNewswire/ -- S&P SmallCap 600 constituent Crocs Inc. (NASD:CROX) will replace Cantel Medical Corp. (NYSE:CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. (NASD: ORGO) will replace Crocs...

CROX : 104.50 (-3.43%)
CMD : 80.37 (-1.18%)
ORGO : 16.51 (-1.43%)
STE : 199.12 (-0.58%)
SPGI : 390.71 (-2.36%)
Organogenesis (ORGO) Surpasses Q1 Earnings and Revenue Estimates

Organogenesis (ORGO) delivered earnings and revenue surprises of 275.00% and 18.83%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

ORGO : 16.51 (-1.43%)
CORRECTING and REPLACING - Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results

In a release issued under the same headline earlier today by Organogenesis Holdings Inc. (Nasdaq: ORGO), please note that in the third bullet of the First Quarter 2021 Financial Results Summary, the net...

ORGO : 16.51 (-1.43%)
Organogenesis Holdings Inc. Reports First Quarter 2021 Financial Results

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical...

ORGO : 16.51 (-1.43%)
Organogenesis Holdings, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 10, 2021 / Organogenesis Holdings, Inc. (NASDAQ:ORGO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 10, 2021 at 5:00...

ORGO : 16.51 (-1.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

See More

Key Turning Points

3rd Resistance Point 17.74
2nd Resistance Point 17.20
1st Resistance Point 16.85
Last Price 16.51
1st Support Level 15.96
2nd Support Level 15.42
3rd Support Level 15.07

See More

52-Week High 24.34
Last Price 16.51
Fibonacci 61.8% 16.27
Fibonacci 50% 13.78
Fibonacci 38.2% 11.29
52-Week Low 3.23

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar